| Bioactivity | HPV16-E711-20 epitope is a well-known HLA-A*0201-restricted human cytotoxic T lymphocyte (CTL) epitope of the HPV16 E7 protein that shows high-affinity binding to HLA-A2 in vitro. HPV16 CTL epitopes may be good candidates for the development of an effective peptide-based antitumor vaccine[1]. |
| Name | HPV16-E711-20 epitope |
| CAS | 160040-04-0 |
| Sequence | Tyr-Met-Leu-Asp-Leu-Gln-Pro-Glu-Thr-Thr |
| Shortening | YMLDLQPETT |
| Formula | C53H83N11O19S |
| Molar Mass | 1210.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
HPV16-E711-20 epitope
CAS: 160040-04-0 F: C53H83N11O19S W: 1210.35
HPV16-E711-20 epitope is a well-known HLA-A*0201-restricted human cytotoxic T lymphocyte (CTL) epitope of the HPV16 E7 p
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.